New lifestyle diseases propel high growth of pharma market August 14, 2016 News RIYADH: A significant rise in lifestyle-related diseases and the developments in health care infrastructure will influence the demand for pharmaceuticals in Saudi Arabia that will reach about SR19.5 billion this year in cumulative cost. Read More
